A Pharmacokinetic Study of Sevoflurane Inhalation in Burn ICU Patients

• Status: Completed
• Trial end date: 2015-09-01
• Target enrollment: 0
• Participant gender: All

Summary

Comparing a pharmacokinetic model of a short sevoflurane sedation in burn ICU patients with control ICU patients.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Clermont-Ferrand
• Treatments: Sevoflurane

Criteria

Inclusion Criteria:

• Adult patients ventilated requiring invasive procedure in ICU

• Stable respiratory and hemodynamic conditions

• Consent of patients or family

• Arterial line

• Burn patients : burn area between 20 and 50% (3rd degree) OR non burn patients

Exclusion Criteria:

• BMI <30

• Sevoflurane anaphylaxia